Syros Pharmaceuticals, Inc. (SYRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Syros Pharmaceuticals, Inc. (SYRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Syros Pharmaceuticals, Inc. (SYRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Syros Pharmaceuticals, Inc. (SYRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
30 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Syros Pharmaceuticals, Inc. (Syros) is a life sciences company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The companys services include gene regulation, new medicines development, genes control, proprietary drug development platform, integrated gene control assay technologies, and computational biology, chemistry, and deep biologic insights solutions. It also provides research and drug development, identifying disease and patient-targeted gene control medicines, therapeutics solutions, differential gene control maps construction, new molecular targets solutions, gene control compounds, and patient lives transformation, among others.

Syros Pharmaceuticals, Inc. (SYRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals

  
Source:
Document ID
GDPH471308D
Country
Industry
Ticker
SYRS=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Syros Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Syros Pharmaceuticals, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Syros Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Syros Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Syros Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Syros Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deal Details1116
  Venture Financing111
    Syros Pharma Raises USD40 Million in Venture Financing112
    Syros Pharma Raises USD53 Million in Series B Venture Financing132
    Syros Pharma Raises US$30 Million In Series A Financing151
    LS22 Raises USD1.25 Million in Venture Financing161
  Partnerships171
    Syros Pharma Enters into Research Agreement171
  Licensing Agreements181
    Syros Pharma Enters into Licensing Agreement with TMRC181
    Syros Pharma Enters into Licensing Agreement with Whitehead Institute192
    Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead212
    Syros Pharma Enters into Licensing Agreement with Dana-Farber Cancer Institute232
  Equity Offering251
    Syros Pharma Raises USD57.5 Million in IPO252
Syros Pharmaceuticals, Inc. - Key Competitors271
Key Employees281
Locations And Subsidiaries291
  Head Office291
Appendix301
  Methodology301
  About GlobalData301
  Contact Us301
  Disclaimer301

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Syros Pharmaceuticals, Inc. (SYRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Syros-Pharmaceuticals-Inc-SYRS-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24965>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Syros Pharmaceuticals, Inc. (SYRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Syros-Pharmaceuticals-Inc-SYRS-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24965>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research